98%
921
2 minutes
20
Excessive dynamic airway collapse (EDAC) contributes to breathlessness and reduced quality of life in individuals with emphysema. We tested a novel, portable, oral positive expiratory pressure (o-PEP) device in a patient with emphysema and EDAC. MRI revealed expiratory tracheal narrowing to 80 mm that increased to 170 mm with the o-PEP device. After 2-weeks use of the o-PEP device for 33% to 66% of activities, breathlessness, quality of life, and exertional dyspnea improved compared with minimal clinically important differences (MCID): University of California-San Diego Shortness of Breath questionnaire score declined 69 to 42 (MCID, ≥5), St. George's Respiratory Questionnaire score decreased 71 to 27 (MCID, ≥4), and before and after the 6-minute walk test Borg score difference improved from Δ3 to Δ2 (MCID, ≥1). During the 6-minute walk test on room air without the use of the o-PEP device, oxyhemoglobin saturation declined 91% to 83%; whereas, with the o-PEP device, the nadir was 90%. Use of the o-PEP device reduced expiratory central airway collapse and improved dyspnea, quality of life, and exertional desaturation in a patient with EDAC and emphysema.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chest.2021.04.059 | DOI Listing |
Cochrane Database Syst Rev
May 2023
Physiotherapy, UCL Great Ormond Street Institute of Child Health, London, UK.
Background: Cystic fibrosis (CF) is an inherited life-limiting disorder. Over time persistent infection and inflammation within the lungs contribute to severe airway damage and loss of respiratory function. Chest physiotherapy, or airway clearance techniques (ACTs), are integral in removing airway secretions and initiated shortly after CF diagnosis.
View Article and Find Full Text PDFRespir Care
March 2023
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; and National TeleCritical Care Program, Veterans Healthcare Administration, Cincinnati, Ohio.
J Appl Physiol (1985)
December 2021
Pulmonary Disease and Critical Care Medicine, University of Vermont College of Medicine, Burlington, Vermont.
Chest
October 2021
Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Medicine, Veterans Affairs Medical Center, Cincinnati, OH.
Excessive dynamic airway collapse (EDAC) contributes to breathlessness and reduced quality of life in individuals with emphysema. We tested a novel, portable, oral positive expiratory pressure (o-PEP) device in a patient with emphysema and EDAC. MRI revealed expiratory tracheal narrowing to 80 mm that increased to 170 mm with the o-PEP device.
View Article and Find Full Text PDFPhysiother Res Int
January 2020
Department of Continuity of Care and Disability, Physical Medicine and Rehabilitation, St Orsola University Hospital, Bologna, Italy.
Background And Purpose: Positive expiratory pressure (PEP)-bottle device delivers a PEP within a range of 10-20 cmH O. PEP treatment is applied to different pathological conditions also in combination with other physiotherapeutic techniques. The primary aim of the present review was to investigate the effects of PEP-bottle therapy in patients with pulmonary diseases and, secondarily, to provide a physiological analysis of its use.
View Article and Find Full Text PDF